Argitalpenak (57) Ikertzaileren baten partaidetza izan duten argitalpenak

2014

  1. Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis

    Molecular Nutrition and Food Research, Vol. 58, Núm. 12, pp. 2379-2382

  2. Actividad de albendazol y los aceites esenciales de menta (Mentha piperita) y manzanilla (Matricaria chamomilla) frente Anisakis tipo I

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 45-49

  3. Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway

    Chemico-Biological Interactions, Vol. 220, pp. 84-93

  4. Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: An uncontrolled, 12-week, pilot study

    Pharmacopsychiatry, Vol. 47, Núm. 2, pp. 67-72

  5. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block

    British Journal of Pharmacology, Vol. 171, Núm. 2, pp. 438-451

  6. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

    Hypertension, Vol. 64, Núm. 2, pp. 330-337

  7. Current status of atypical antipsychotics for the treatment of fibromyalgia

    Drugs of Today, Vol. 50, Núm. 6, pp. 435-444

  8. Diagnosis of leishmaniasis

    Journal of Infection in Developing Countries, Vol. 8, Núm. 8, pp. 961-972

  9. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population

    European Journal of Pain (United Kingdom), Vol. 18, Núm. 1, pp. 101-109

  10. Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration

    Neuron, Vol. 83, Núm. 2, pp. 331-343

  11. Drug assessment by a Pharmacy and Therapeutics committee: From drug selection criteria to use in clinical practice

    Therapeutics and Clinical Risk Management, Vol. 10, Núm. 1, pp. 527-535

  12. Efectos de un programa de Atención Farmacéutica para pacientes con esclerosis múltiple sobre la adherencia al tratamiento inmunomodulador

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 37-44

  13. Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients

    British Journal of Clinical Pharmacology, Vol. 78, Núm. 6, pp. 1366-1377

  14. Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese

    Food and Chemical Toxicology, Vol. 73, pp. 113-118

  15. Fibromyalgia: Comorbidity indicative of vulnerability?

    Medicina Clinica, Vol. 142, Núm. 12, pp. 538-539

  16. Food derived bioactive peptides and intestinal barrier function

    International Journal of Molecular Sciences, Vol. 15, Núm. 12, pp. 22857-22873

  17. Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms

    PLoS ONE, Vol. 9, Núm. 1

  18. Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation

    Pflugers Archiv European Journal of Physiology, Vol. 466, Núm. 2, pp. 237-251

  19. Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice

    Molecular Pain, Vol. 10, Núm. 1

  20. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound

    Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606